Related Experiment Videos
Bullous pemphigoid successfully controlled by tetracycline and nicotinamide
D N Kolbach1, J J Remme, W H Bos
1Department of Dermatology, Academisch Ziekenhuis, Groningen, Velsen, The Netherlands.
The British Journal of Dermatology
|July 1, 1995
Summary
This study found that a combination of tetracycline and nicotinamide effectively treated bullous pemphigoid (BP) skin lesions, achieving remission in patients within 6-8 weeks. The treatment regimen involved 2g of each daily for a mean of 7 months.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Bullous pemphigoid (BP) is an autoimmune blistering skin disease.
- Previous research by Berk and Lorincz in 1986 suggested tetracycline and nicotinamide efficacy for BP.
Purpose of the Study:
- To evaluate the efficacy of a combined tetracycline and nicotinamide regimen in treating bullous pemphigoid.
- To assess the time to remission and duration of therapy required for BP management.
Main Methods:
- A study involving seven patients diagnosed with bullous pemphigoid.
- Administered a daily regimen of 2 grams of tetracycline and 2 grams of nicotinamide.
Main Results:
- The combined therapy effectively cleared skin lesions in all seven patients.
- Total remission was achieved within 6 to 8 weeks of treatment initiation.
- The mean duration of therapy was 7 months, with gradual dose tapering post-remission.
Conclusions:
- The combination of tetracycline and nicotinamide is an effective treatment for bullous pemphigoid.
- This regimen leads to rapid skin lesion clearance and sustained remission.
- The underlying mechanism of action for this therapeutic approach remains undetermined.